Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Supporting the spread and scale-up of electronic consultation across Canada: cross-sectional analysis.

Liddy C, Bello A, Cook J, Drimer N, Pilon MD, Farrell G, Glassford J, Ireland L, McDonald R, Nabelsi V, Oppenheimer L, Singer A, Keely E.

BMJ Open. 2019 May 30;9(5):e028888. doi: 10.1136/bmjopen-2018-028888.

2.

The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Glassford JA.

Front Physiol. 2017 Feb 17;8:88. doi: 10.3389/fphys.2017.00088. eCollection 2017.

3.

Patient and provider perspectives on the design and implementation of an electronic consultation system for kidney care delivery in Canada: a focus group study.

Bello AK, Molzahn AE, Girard LP, Osman MA, Okpechi IG, Glassford J, Thompson S, Keely E, Liddy C, Manns B, Jinda K, Klarenbach S, Hemmelgarn B, Tonelli M.

BMJ Open. 2017 Mar 2;7(3):e014784. doi: 10.1136/bmjopen-2016-014784.

4.

Inhibition of cell cycle progression by dual phosphatidylinositol-3-kinase and mTOR blockade in cyclin D2 positive multiple myeloma bearing IgH translocations.

Glassford J, Kassen D, Quinn J, Stengel C, Kallinikou K, Khwaja A, Yong KL.

Blood Cancer J. 2012 Jan;2(1):e50. doi: 10.1038/bcj.2011.44. Epub 2012 Jan 13.

5.

APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation status.

Quinn J, Glassford J, Percy L, Munson P, Marafioti T, Rodriguez-Justo M, Yong K.

Blood. 2011 Jan 20;117(3):890-901. doi: 10.1182/blood-2010-01-264424. Epub 2010 Aug 13.

6.

CD20-positive multiple myeloma - differential expression of cyclins D1 and D2 suggests a heterogeneous disease.

Quinn J, Percy L, Glassford J, Somana K, Rodriguez-Justo M, Yong K.

Br J Haematol. 2010 Apr;149(1):156-9. doi: 10.1111/j.1365-2141.2009.08030.x. Epub 2009 Dec 7. No abstract available.

PMID:
19995388
7.

Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.

Glassford J, Rabin N, Lam EW, Yong KL.

Br J Haematol. 2007 Oct;139(2):243-54.

PMID:
17897300
8.

A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transfer.

Rabin N, Kyriakou C, Coulton L, Gallagher OM, Buckle C, Benjamin R, Singh N, Glassford J, Otsuki T, Nathwani AC, Croucher PI, Yong KL.

Leukemia. 2007 Oct;21(10):2181-91. Epub 2007 Jul 26.

PMID:
17657224
9.

p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo.

Soeiro I, Mohamedali A, Romanska HM, Lea NC, Child ES, Glassford J, Orr SJ, Roberts C, Naresh KN, Lalani el-N, Mann DJ, Watson RJ, Thomas NS, Lam EW.

Mol Cell Biol. 2006 Aug;26(16):6170-84.

10.

Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes.

Glassford J, Vigorito E, Soeiro I, Madureira PA, Zoumpoulidou G, Brosens JJ, Turner M, Lam EW.

Eur J Immunol. 2005 Sep;35(9):2748-61.

11.

Vav-dependent and vav-independent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus.

Vigorito E, Bardi G, Glassford J, Lam EW, Clayton E, Turner M.

J Immunol. 2004 Sep 1;173(5):3209-14.

12.

Cyclin D2 controls B cell progenitor numbers.

Mohamedali A, Soeiro I, Lea NC, Glassford J, Banerji L, Mufti GJ, Lam EW, Thomas NS.

J Leukoc Biol. 2003 Dec;74(6):1139-43. Epub 2003 Nov 11.

PMID:
14612431
13.

BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.

Glassford J, Soeiro I, Skarell SM, Banerji L, Holman M, Klaus GG, Kadowaki T, Koyasu S, Lam EW.

Oncogene. 2003 Apr 17;22(15):2248-59.

PMID:
12700661
14.

Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors.

Kops GJ, Medema RH, Glassford J, Essers MA, Dijkers PF, Coffer PJ, Lam EW, Burgering BM.

Mol Cell Biol. 2002 Apr;22(7):2025-36.

15.

H2O2 induces a transient multi-phase cell cycle arrest in mouse fibroblasts through modulating cyclin D and p21Cip1 expression.

Barnouin K, Dubuisson ML, Child ES, Fernandez de Mattos S, Glassford J, Medema RH, Mann DJ, Lam EW.

J Biol Chem. 2002 Apr 19;277(16):13761-70. Epub 2002 Feb 4.

16.

BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.

Banerji L, Glassford J, Lea NC, Thomas NS, Klaus GG, Lam EW.

Oncogene. 2001 Nov 1;20(50):7352-67.

17.

Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen Receptor.

Glassford J, Holman M, Banerji L, Clayton E, Klaus GG, Turner M, Lam EW.

J Biol Chem. 2001 Nov 2;276(44):41040-8. Epub 2001 Sep 6.

18.

BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression.

Parada Y, Banerji L, Glassford J, Lea NC, Collado M, Rivas C, Lewis JL, Gordon MY, Thomas NS, Lam EW.

J Biol Chem. 2001 Jun 29;276(26):23572-80. Epub 2001 Apr 25.

19.

The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells.

Lewis JL, Chinswangwatanakul W, Zheng B, Marley SB, Nguyen DX, Cross NC, Banerji L, Glassford J, Thomas NS, Goldman JM, Lam EW, Gordon MY.

Blood. 2001 May 1;97(9):2604-10.

20.

Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1.

Collado M, Medema RH, Garcia-Cao I, Dubuisson ML, Barradas M, Glassford J, Rivas C, Burgering BM, Serrano M, Lam EW.

J Biol Chem. 2000 Jul 21;275(29):21960-8.

21.

Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development.

Solvason N, Wu WW, Parry D, Mahony D, Lam EW, Glassford J, Klaus GG, Sicinski P, Weinberg R, Liu YJ, Howard M, Lees E.

Int Immunol. 2000 May;12(5):631-8.

PMID:
10784609
22.

Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40.

Lam EW, Glassford J, Banerji L, Thomas NS, Sicinski P, Klaus GG.

J Biol Chem. 2000 Feb 4;275(5):3479-84.

23.

Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors.

Lam EW, Glassford J, van der Sman J, Banerji L, Pizzey AR, Shaun N, Thomas B, Klaus GG.

Eur J Immunol. 1999 Oct;29(10):3380-9.

25.

Caesarean section in a patient with Cushing's syndrome.

Glassford J, Eagle C, McMorland GH.

Can Anaesth Soc J. 1984 Jul;31(4):447-50.

PMID:
6744093
26.

Treatment of EGG-retention in a turtle.

Glassford JF, Brown K.

Vet Med Small Anim Clin. 1977 Oct;72(10):1641-5. No abstract available.

PMID:
243319

Supplemental Content

Loading ...
Support Center